However, due to extensive reports of systemic and CNS innate immune and inflammatory activation in human HD patients and HD mouse models [2–9], it has been proposed that innate immune activation may play a role in mediating the pathogenic effects of mutant huntingtin (mHTT). Here, HTT is linked to Huntington disease.